Kevin C. O'COnnor

Kevin C. O'COnnor

Auto-generated profile, based on publicly available information

Kevin C. O'COnnor

Departments of Neurology and Immunobiology, Yale School of Medicine, Yale University, New Haven, CT

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2014 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
JSJoel N. H. Stern
Joel N. H. Stern
GYGur Yaari
Gur Yaari
JHJason A. Vander Heiden
Jason A. Vander Heiden
GCGeorge Church
George Church
WDWilliam F. Donahue
William F. Donahue
KOKevin C. O’connor
Kevin C. O’connor
In multiple sclerosis patients, B cells mature in the draining cervical lymph nodes before trafficking across the blood-brain barrier.

1 January 2013 in Frontiers in Immunology
Verified
Journal Article
Open access
GYGur Yaari
Gur Yaari
JHJason A. Vander Heiden
Jason A. Vander Heiden
MUMohamed Uduman
Mohamed Uduman
DGDaniel Gadala-Maria
Daniel Gadala-Maria
NGNamita Gupta
Namita Gupta
SKSteven H. Kleinstein
Steven H. Kleinstein
Analyses of somatic hypermutation (SHM) patterns in B cell immunoglobulin (Ig) sequences contribute to our basic understanding of adaptive immunity, and have broad applications not only for understanding the immune response to pathogens, but also to determining the role of SHM in autoimmunity and B cell cancers. Although stochastic, SHM displays intrinsic biases that can confound statistical analysis, especially when combined with the particular codon usage and base composition in Ig sequences. Analysis of B cell clonal expansion, diversification, and selection processes thus critically depends on an accurate background model for SHM micro-sequence targeting (i.e., hot/cold-spots) and nucleotide substitution. Existing models are based on small numbers of sequences/mutations, in part because they depend on data from non-coding regions or non-functional sequences to remove the confounding influences of selection. Here, we combine high-throughput Ig sequencing with new computational analysis methods to produce improved models of SHM targeting and substitution that are based only on synonymous mutations, and are thus independent of selection. The resulting “S5F” models are based on 806,860 Synonymous mutations in 5-mer motifs from 1,145,182 Functional sequences and account for dependencies on the adjacent four nucleotides (two bases upstream and downstream of the mutation). The estimated profiles can explain almost half of the variance in observed mutation patterns, and clearly show that both mutation targeting and substitution are significantly influenced by neighboring bases. While mutability and substitution profiles were highly conserved across individuals, the variability across motifs was found to be much larger than previously estimated. The model and method source code are made available at http://clip.med.yale.edu/SHM

7 January 2011 in Brain
Verified
Journal Article
Open access
PDF file
LLLaura Lovato
Laura Lovato
SWSimon N. Willis
Simon N. Willis
SRScott J. Rodig
Scott J. Rodig
TCTyler Caron
Tyler Caron
SAStefany E. Almendinger
Stefany E. Almendinger
DHDavid A. Hafler
David A. Hafler
In the central nervous system of patients with multiple sclerosis, B cell aggregates populate the meninges, raising the central question as to whether these structures relate to the B cell infiltrates found in parenchymal lesions or instead, represent a separate central nervous system immune compartment. We characterized the repertoires derived from meningeal B cell aggregates and the corresponding parenchymal infiltrates from brain tissue derived primarily from patients with progressive multiple sclerosis. The majority of expanded antigen-experienced B cell clones derived from meningeal aggregates were also present in the parenchyma. We extended this investigation to include 20 grey matter specimens containing meninges, 26 inflammatory plaques, 19 areas of normal appearing white matter and cerebral spinal fluid. Analysis of 1833 B cell receptor heavy chain variable region sequences demonstrated that antigen-experienced clones were consistently shared among these distinct compartments. This study establishes a relationship between extraparenchymal lymphoid tissue and parenchymal infiltrates and defines the arrangement of B cell clones that populate the central nervous system of patients with multiple sclerosis.

19 January 2023 in Nature Biotechnology
Verified
Journal Article
Open access
PDF file
SOSangwook Oh
Sangwook Oh
XMXuming Mao
Xuming Mao
SMSilvio Manfredo-Vieira
Silvio Manfredo-Vieira
JLJinmin Lee
Jinmin Lee
DPDarshil Patel
Darshil Patel
APAimee S. Payne
Aimee S. Payne
Muscle-specific tyrosine kinase myasthenia gravis (MuSK MG) is an autoimmune disease that causes life-threatening muscle weakness due to anti-MuSK autoantibodies that disrupt neuromuscular junction signaling. To avoid chronic immunosuppression from current therapies, we engineered T cells to express a MuSK chimeric autoantibody receptor with CD137-CD3ζ signaling domains (MuSK-CAART) for precision targeting of B cells expressing anti-MuSK autoantibodies. MuSK-CAART demonstrated similar efficacy as anti-CD19 chimeric antigen receptor T cells for depletion of anti-MuSK B cells and retained cytolytic activity in the presence of soluble anti-MuSK antibodies. In an experimental autoimmune MG mouse model, MuSK-CAART reduced anti-MuSK IgG without decreasing B cells or total IgG levels, reflecting MuSK-specific B cell depletion. Specific off-target interactions of MuSK-CAART were not identified in vivo, in primary human cell screens or by high-throughput human membrane proteome array. These data contributed to an investigational new drug application and phase 1 clinical study design for MuSK-CAART for the treatment of MuSK autoantibody-positive MG.


20 September 2017 in Muscle & Nerve
Verified
Journal Article
Closed access
PDF file
JYJohn S. Yi
John S. Yi
JGJeffrey T. Guptill
Jeffrey T. Guptill
PSPanos Stathopoulos
Panos Stathopoulos
RNRichard J. Nowak
Richard J. Nowak
KOKevin C. O’connor
Kevin C. O’connor